The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Neglected Tropical Diseases Continue To Plague South Asia Despite Economic Growth
A new report showcases the disproportionately high burden of neglected tropical diseases in India and South Asia that continue to plague the 1.5 billion people living in the region.
Academia Sinica’s Dr. Li-Huei Tsai Elected To The US Institute Of Medicine
Dr. Li-Huei Tsai of Taiwan's Academia Sinica has been elected a member of the US Institute of Medicine.
Presenting Danica May Camacho Of Manila, Philippines… The World’s 7 Billionth Baby
Baby Danica May Camacho of the Philippines has been chosen by the United Nations as the symbolic seven billionth baby to be born worldwide.
Researchers Visualize Retinoic Acid Gradient In Live Embryo
Researchers in Japan have developed a new technique that enabled them to visualize the distribution of retinoic acid in a live zebrafish embryo, in real-time.
Scientists Find Gene For Hereditary Epilepsy
Researchers have tracked a hereditary gene responsible for a common form of epilepsy known as focal or partial epilepsy.
Sing-Song Cantonese Language Helps Musicality, Study
Non-musicians who speak tonal languages such as Cantonese may have a better ear for learning musical notes, says a new study.
How Do We Feed India’s Population In 2050?
The average Indian consumes only 2,300 calories per day - below the poverty level of 2,400 calories a day. The trend in recent years is for Indians to eat even less, writes Ranjit Goswami.
China To Launch Earth Observation Satellite This Month
China is planning to launch a high-resolution Earth observation satellite this month.
Astellas, Ambryx Sign US$300 Million Antibody Drug Conjugate Deal
Astellas Pharma Inc. on Thursday entered into a collaboration with Ambrx Inc. for the discovery and development of novel antibody drug conjugates.